Search clinical trials for: LAS41007

Total 13 results

Almirall, S.A.

Completed

Efficacy and Safety Study of LAS41007 in the Treatment of Actinic Keratosis

Actinic Keratosis

Germany
Almirall, S.A.

Completed

Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic Keratosis

Actinic Keratosis

Germany
Almirall, S.A.
proDERM GmbH

Completed

Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test

Psoriasis

Germany
Almirall, S.A.
Sciderm GmbH

Completed

Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque Test

Psoriasis

Germany
Almirall, S.A.

Completed

A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate Psoriasis (Left/Right)

Psoriasis

Germany
Almirall, S.A.

Completed

LAS41005 in Hyperkeratotic Actinic Keratosis

Actinic Keratosis

Germany
Almirall, S.A.

Completed

Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis

Actinic Keratosis

Germany
Almirall, S.A.
proDERM GmbH

Completed

Efficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque Test (PPT4)

Psoriasis

Germany
Almirall, S.A.

Completed

Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected Eczema

Eczema

Germany
Almirall, S.A.

Completed

Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008 (LAS41008)

Psoriasis

United Kingdom
Almirall, S.A.

Completed

Efficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea Pedis

Tinea Pedis

Germany
Almirall, S.A.

Completed

Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections

Candidiasis

Germany
Almirall, S.A.
Harrison Clinical Research; Almirall Hermal GmbH

Completed

LAS41008 in Moderate to Severe Chronic Plaque Psoriasis

Plaque Psoriasis

Austria, Germany, Netherlands, Poland

3

Subscribe